One Partner-Every Step of Your Device's Journey

May 12, 2026

Sean Slavin

Medical Device Packaging

Co-authored by Averra Packaging + ZIEN Medical

June 16, 2025 · Press Release · 5 min read

One Partner. Every Step of Your Device's Journey.

The medical device industry has always demanded both precision engineering and flawless packaging. Until now, those two worlds often required two different partners. That changes today.

Averra Holdings and Banner Capital are pleased to announce a partnership with ZIEN Medical Technologies — forming a single, vertically integrated organization capable of taking a medical device concept from initial design all the way through manufacturing, packaging, sterilization, and regulatory approval.

Two Organizations, One Mission

Averra Packaging, founded in 1989, has spent more than three decades mastering medical device packaging. Specializing in thermoformed and flexible packaging, Averra brings full in-house design, prototyping, tooling, and production — all built to meet sterile performance requirements.

ZIEN Medical Technologies, founded in 2009, is a vertically integrated contract design and manufacturing organization (CDMO) with deep expertise in product design and development, cost optimization, manufacturing, packaging, sterilization, and quality and regulatory services.

Together, under the Averra Holdings umbrella and backed by Banner Capital, the combined organization offers what the market has been asking for: a single, trusted partner for the entire device lifecycle.

What the Combined Organization Delivers

Product Design & Development
Contract Manufacturing
Turnkey Sterile Packaging
Sterilization Services
Quality & Regulatory Support
Cost Optimization

Why It Matters for Medical Device Companies

Building a medical device typically means managing a fragmented supply chain — design firms, manufacturers, packaging specialists, sterilization vendors, and regulatory consultants operating in separate silos. Handoffs introduce risk. Timelines stretch. Costs compound.

The Averra + ZIEN combination directly addresses this challenge. For medtech innovators — whether a startup racing toward first-in-human or an established OEM looking to streamline — this partnership offers a level of integration that is rare in the industry.

With renewed national emphasis on domestic manufacturing, the combined platform also provides a U.S.-based, vertically integrated supply chain that reduces exposure and strengthens business continuity.

In Their Own Words

"The partnership with ZIEN demonstrates Averra's commitment to the medical device space and supports our mission to be a full-service provider of products and services to the industry. The combination of Averra and ZIEN creates an enterprise that is greater than the sum of its parts."

— Jeremy Horton, President, Averra / ZIEN

"Outcome Capital's deep insight and counsel played a key role in guiding us to combine services and achieve this successful transaction. Our team is eager to integrate and grow our impact."

— Tim Nieman, CEO, Averra / ZIEN

"ZIEN and Averra have tremendous tailwinds with renewed interest in domestic manufacturing, high demand for vertically integrated services, and a tailored platform for medtech companies to turn to."

— Thomas Busby, Director, Outcome Capital

Looking Ahead

The medical device industry is at an inflection point. Demand for innovative devices continues to rise. Regulatory complexity is increasing. And the pressure to bring products to market faster — and at lower cost — has never been greater.

Averra Holdings is building the platform that meets this moment. With ZIEN now a division of Averra Holdings, clients gain access to a seamlessly integrated team that can accompany a product from concept to a sterile, validated, market-ready device — all within a single relationship.

Official Announcements

Ready to explore what a fully integrated device partner can do for your next product?

Connect with Averra

‍

Back